Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
2018 · JAMA Oncology · 2,473 citations
https://doi.org/10.1001/jamaoncol.2018.3923
J
Justine V. Cohen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
242
Papers
11.9K
Citations
43
h-index
80
i10-index
Justine V. Cohen is an academic researcher from Boston University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Brain Metastases and Treatment & Melanoma and MAPK Pathways. The author has an h-index of 43, co-authored 206 publications.
ORCID: 0000-0003-4803-9230Papers by this author
worksMyocarditis in Patients Treated With Immune Checkpoint Inhibitors
2018 · Journal of the American College of Cardiology · 1,482 citations
https://doi.org/10.1016/j.jacc.2018.02.037
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
2016 · The Lancet Oncology · 987 citations
https://doi.org/10.1016/s1470-2045(16)30053-5
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
2021 · Nature Communications · 87 citations
https://doi.org/10.1038/s41467-021-25859-y
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
2020 · British Journal of Cancer · 61 citations
https://doi.org/10.1038/s41416-020-01121-y
Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision
2021 · Journal of the American Academy of Dermatology · 54 citations
https://doi.org/10.1016/j.jaad.2021.04.090
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat